PinnedBioStrand (a subsidiary of IPA)Multimodal language models in protein engineering: Functional clonotyping & beyondIn the beginning of 2023, ChatGPT achieved a significant milestone of 100 million users. The utilization of generative AI defined the year…Feb 1Feb 1
PinnedBioStrand (a subsidiary of IPA)Explained: how to plot the prediction quality metrics with AlphaFold2In a previous blog post , we discussed the importance of AlphaFold2 (as well as other, deep-learning based methods) to accelerate the…Jan 9, 2023Jan 9, 2023
BioStrand (a subsidiary of IPA)Transforming drug design: Vector search in text analysisAI-Driven Rational Drug Design is central to BioStrand’s mission to power the intersection of biotech discovery, biotherapeutics and AI…Jun 13Jun 13
BioStrand (a subsidiary of IPA)High-throughput in silico epitope binning, with in vitro grade accuracyEfficient, scalable antibody drug discovery and development is grounded in the high-throughput isolation of substantial quantities of…May 30May 30
BioStrand (a subsidiary of IPA)Epitope binning explained: A powerful tool for antibody developmentEpitope-based screening approaches are playing a pivotal role in the development of modern antibody therapies for various diseases…May 7May 7
BioStrand (a subsidiary of IPA)Private Conda package servers: Choosing the right solutionIf you are a newcomer to the Python ecosystem, it can be daunting to know how to setup your python environment. There are tens of…Apr 9Apr 9
BioStrand (a subsidiary of IPA)Generative AI in drug discoveryFollowing a breakout year of rapid growth, generative AI has been widely, and justifiably, described as an undisputed game-changer for…Feb 20Feb 20
BioStrand (a subsidiary of IPA)Biomedical knowledge graphs and the power of ontologyKnowledge graphs play a crucial role in the organization, integration, and interpretation of vast volumes of heterogeneous life sciences…Jan 23Jan 23
BioStrand (a subsidiary of IPA)Mitigating LLM HallucinationsHowever, there are still several challenges that have to be addressed before LLMs can be reliably integrated into in-silico drug discovery…Jan 91Jan 91
BioStrand (a subsidiary of IPA)How retrieval-augmented generation (RAG) can transform drug discoveryIn a recent article on knowledge graphs and large language models (LLMs) in drug discovery, we noted that despite the transformative…Dec 14, 2023Dec 14, 2023